AbbVie, a research-based global biopharmaceutical company, has today announced that it has been declared the top pharmaceutical company to work for in Saudi Arabia by Great Place to Work® for the 6th consecutive year.
Ashraf Daoud, general manager of AbbVie in Saudi Arabia, said, “Being recognized by Great Place to Work for six consecutive years is truly unprecedented and a shining example of the amazing group of exceptional people we have at AbbVie. I am incredibly grateful to be able to work alongside a team of dedicated professionals who tirelessly work together with a spirit of collaboration, mutual respect, enthusiasm, and who inspire and encourage each other every day to make a remarkable impact on people’s lives, even when faced with the current pandemic. This prestigious award gives us even more motivation and resolve to elevate our work standards, focus on core priorities of instilling a healthy, high-performing workplace culture and environment, as well as developing local talent throughout 2020 and beyond.”
As a global leader in the biopharmaceuticals industry, AbbVie has a broad portfolio of market leading medicines for the treatment of the world’s most complex and serious diseases.
Khaled Fageha, human resources director at AbbVie, commented, “At AbbVie, we aim to create a thriving workplace culture by engaging with our employees in the most meaningful ways. We are always looking at the best ways to build upon our work environment to inspire innovation, personal development, inclusion and collaboration. By guaranteeing our employees are motivated, satisfied and happy in the workplace, they are more engaged which, ultimately, benefits their performance and increases employee retention.”
AbbVie is playing a major role in upskilling local Saudi talent in order to inspire them to join the private pharmaceutical sector, highlighting its support towards the Government’s localization goals and this has been seen a rise in the percentage of Saudi nationals across various functions in the pharmaceutical industry, AbbVie’s on-going efforts in this area is supporting the Kingdom’s goals to upskill current and aspiring Saudi pharmacists, as outlined in Vision 2030,”
"The rate of Saudization at AbbVie has increased by 30% over the past 2 years, especially in the product specialist role, which reached up to 70% of the current workforce working in this role,” said Khaled Fageha. “Inspiring women to work in various fields across the pharmaceutical sector is a top priority at AbbVie and already we are seeing this bear fruit following an increase of 25% in female employment during the past year.”
Enas Al-Mohammadi, a Saudi pharmacist who was recently hired as a product specialist after AbbVie’s annual training program, said: “AbbVie boasts a dynamic and positive working culture, and it has been a terrific experience being part of a global pharmaceutical company. I have continued to learn and grow during my time here, and I am extremely proud to be able to help the lives of patients in our local Saudi community, especially during the pandemic.”
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.